INS and cardiovascular disorder: In model 2, which was adjusted for model 1 + diabetes duration, cardiovascular diseases history, and drug usage (ARBs, ACEIs, beta-blockers, metformin, sulphonyl urea, and insulin), the inverse association remained (OR: 0.16; 95% CI 0.07–0.34; P < 0.001).